Drug Profile
Research programme: MERS vaccines - Replikins
Alternative Names: MERS blocker-vaccine; MERS Replikins Synthetic Vaccine-Blocker; MERS synthetic Replikins vaccineLatest Information Update: 23 Aug 2023
Price :
$50
*
At a glance
- Originator Replikins
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Middle East respiratory syndrome coronavirus
Most Recent Events
- 23 Aug 2023 Discontinued - Preclinical for Middle East respiratory syndrome coronavirus (Prevention) in USA (Parenteral)
- 28 Jul 2019 No recent reports of development identified for preclinical development in Middle-East-respiratory-syndrome-coronavirus(Prevention) in USA (Parenteral)
- 04 Jun 2015 Preclinical trials in Middle East respiratory syndrome coronavirus (Prevention) in USA (Parenteral)